According to the public relations and information center of the Vice-Presidency for science and technology affairs, Amir Ali Hamidieh, secretary of soft and identity-making technologies, expressed his hope that more developments will be observed in knowledge-based companies in the area of stem cells and regenerative medicine in this year. These companies must be able to supply the needs of the country in order to move toward self-efficiency and more saving of foreign currency. In addition, their productions in the country will eliminate the need for costly export of products in this area.

In this meeting, the knowledge-based company of medicine and industry of Rahyab presented its products with the title of “cell separation, application, and potentials”. According to this report, a part of research of this knowledge-based company has led to the production and commercialization of the device and columns of cell separation with Magsieve brand, which is a suitable replacement for its foreign counterpart (Miltenyi Biotech). The products of this brand are inclusive and extremely costly.

In addition, this knowledge-based company has been able to obtain the confirmation of blood transfer organization based on the accuracy of the device and columns of cell separation. Similar to its foreign counterparts, the new design of this device has an appealing presence and can be easily used.

During the meeting, the knowledge-based company of Alvand presented its design of the formulation and industrial production of injectable busulfan medication in the form of a solution to implant hematopoietic stem cells.

The last design presented in the meeting was from Ilia company with the title of “semi-industrial production of amphotericin B liposomal. Amphotericin B is available on the market with amphoteric and embizic brand names. In addition, this medication exists in the form of injectable and topical on the skin, as well as creams and lotions.

The 15^th meeting of the workgroup of knowledge-based companies of soft and identity-making technologies development headquarter was held in the presence of Amir Ali Hamidieh, secretary of the mentioned headquarter, Alireza Sho’a Hasani, manager of technology, commercialization and market, and active representatives of companies in the area of stem cells and regenerative medicine in the Vice-Presidency for science and technology affairs.